{"id":"https://openalex.org/W2305141757","doi":"https://doi.org/10.1117/12.2214230","title":"Applying quantitative adiposity feature analysis models to predict benefit of bevacizumab-based chemotherapy in ovarian cancer patients","display_name":"Applying quantitative adiposity feature analysis models to predict benefit of bevacizumab-based chemotherapy in ovarian cancer patients","publication_year":2016,"publication_date":"2016-03-24","ids":{"openalex":"https://openalex.org/W2305141757","doi":"https://doi.org/10.1117/12.2214230","mag":"2305141757"},"language":"en","primary_location":{"id":"doi:10.1117/12.2214230","is_oa":false,"landing_page_url":"https://doi.org/10.1117/12.2214230","pdf_url":null,"source":{"id":"https://openalex.org/S183492911","display_name":"Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE","issn_l":"0277-786X","issn":["0277-786X","1996-756X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310315543","host_organization_name":"SPIE","host_organization_lineage":["https://openalex.org/P4310315543"],"host_organization_lineage_names":["SPIE"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SPIE Proceedings","raw_type":"proceedings-article"},"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101572876","display_name":"Yunzhi Wang","orcid":"https://orcid.org/0000-0001-9033-3156"},"institutions":[{"id":"https://openalex.org/I8692664","display_name":"University of Oklahoma","ror":"https://ror.org/02aqsxs83","country_code":"US","type":"education","lineage":["https://openalex.org/I8692664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yunzhi Wang","raw_affiliation_strings":["The Univ. of Oklahoma (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Univ. of Oklahoma (United States)","institution_ids":["https://openalex.org/I8692664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036245571","display_name":"Yuchen Qiu","orcid":"https://orcid.org/0000-0001-6047-7204"},"institutions":[{"id":"https://openalex.org/I8692664","display_name":"University of Oklahoma","ror":"https://ror.org/02aqsxs83","country_code":"US","type":"education","lineage":["https://openalex.org/I8692664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuchen Qiu","raw_affiliation_strings":["The Univ. of Oklahoma (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Univ. of Oklahoma (United States)","institution_ids":["https://openalex.org/I8692664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113128567","display_name":"Theresa Thai","orcid":null},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Theresa Thai","raw_affiliation_strings":["The Univ. of Oklahoma Health Sciences Ctr. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Univ. of Oklahoma Health Sciences Ctr. (United States)","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063013447","display_name":"Kathleen More","orcid":null},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen More","raw_affiliation_strings":["The Univ. of Oklahoma Health Sciences Ctr. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Univ. of Oklahoma Health Sciences Ctr. (United States)","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101873753","display_name":"Kai Ding","orcid":"https://orcid.org/0000-0001-9475-437X"},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kai Ding","raw_affiliation_strings":["The Univ. of Oklahoma Health Sciences Ctr. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Univ. of Oklahoma Health Sciences Ctr. (United States)","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100410286","display_name":"Hong Liu","orcid":"https://orcid.org/0000-0002-0896-8409"},"institutions":[{"id":"https://openalex.org/I8692664","display_name":"University of Oklahoma","ror":"https://ror.org/02aqsxs83","country_code":"US","type":"education","lineage":["https://openalex.org/I8692664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hong Liu","raw_affiliation_strings":["The Univ. of Oklahoma (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Univ. of Oklahoma (United States)","institution_ids":["https://openalex.org/I8692664"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045998635","display_name":"Bin Zheng","orcid":"https://orcid.org/0000-0002-7682-6648"},"institutions":[{"id":"https://openalex.org/I8692664","display_name":"University of Oklahoma","ror":"https://ror.org/02aqsxs83","country_code":"US","type":"education","lineage":["https://openalex.org/I8692664"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bin Zheng","raw_affiliation_strings":["The Univ. of Oklahoma (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Univ. of Oklahoma (United States)","institution_ids":["https://openalex.org/I8692664"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.01967464,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"9785","issue":null,"first_page":"97850U","last_page":"97850U"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10515","display_name":"Cancer-related molecular mechanisms research","score":0.9853000044822693,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.9664999842643738,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"Bevacizumab","score":0.8515108823776245},{"id":"https://openalex.org/keywords/logistic-regression","display_name":"Logistic regression","score":0.67335045337677},{"id":"https://openalex.org/keywords/internal-medicine","display_name":"Internal medicine","score":0.6346428394317627},{"id":"https://openalex.org/keywords/medicine","display_name":"Medicine","score":0.6236163973808289},{"id":"https://openalex.org/keywords/oncology","display_name":"Oncology","score":0.621803343296051},{"id":"https://openalex.org/keywords/multivariate-statistics","display_name":"Multivariate statistics","score":0.5460389852523804},{"id":"https://openalex.org/keywords/proportional-hazards-model","display_name":"Proportional hazards model","score":0.5440293550491333},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"Ovarian cancer","score":0.5250023603439331},{"id":"https://openalex.org/keywords/multivariate-analysis","display_name":"Multivariate analysis","score":0.4526500701904297},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"Chemotherapy","score":0.37878063321113586},{"id":"https://openalex.org/keywords/cancer","display_name":"Cancer","score":0.35870158672332764},{"id":"https://openalex.org/keywords/machine-learning","display_name":"Machine learning","score":0.23318752646446228},{"id":"https://openalex.org/keywords/computer-science","display_name":"Computer science","score":0.22401800751686096}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8515108823776245},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.67335045337677},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6346428394317627},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6236163973808289},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.621803343296051},{"id":"https://openalex.org/C161584116","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate statistics","level":2,"score":0.5460389852523804},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5440293550491333},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5250023603439331},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.4526500701904297},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.37878063321113586},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35870158672332764},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.23318752646446228},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.22401800751686096}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1117/12.2214230","is_oa":false,"landing_page_url":"https://doi.org/10.1117/12.2214230","pdf_url":null,"source":{"id":"https://openalex.org/S183492911","display_name":"Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE","issn_l":"0277-786X","issn":["0277-786X","1996-756X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310315543","host_organization_name":"SPIE","host_organization_lineage":["https://openalex.org/P4310315543"],"host_organization_lineage_names":["SPIE"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SPIE Proceedings","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.7300000190734863}],"awards":[],"funders":[{"id":"https://openalex.org/F4320310627","display_name":"Oklahoma Center for the Advancement of Science and Technology","ror":"https://ror.org/02q578v20"},{"id":"https://openalex.org/F4320315709","display_name":"Tobacco Settlement Endowment Trust","ror":null},{"id":"https://openalex.org/F4320333795","display_name":"Stephenson Cancer Center","ror":null}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1966847100","https://openalex.org/W1973948212","https://openalex.org/W1980968791","https://openalex.org/W1996518952","https://openalex.org/W2034562813","https://openalex.org/W2079035144","https://openalex.org/W2113122060","https://openalex.org/W2125943933","https://openalex.org/W2136883754","https://openalex.org/W2160921359","https://openalex.org/W2220907510","https://openalex.org/W2295384772","https://openalex.org/W4239851916","https://openalex.org/W6688883094","https://openalex.org/W6697375291"],"related_works":["https://openalex.org/W4225091507","https://openalex.org/W2406638334","https://openalex.org/W40745829","https://openalex.org/W1978357124","https://openalex.org/W1974427739","https://openalex.org/W1578824628","https://openalex.org/W2032728545","https://openalex.org/W1570805059","https://openalex.org/W4250754046","https://openalex.org/W4318262572"],"abstract_inverted_index":{"How":[0],"to":[1,31,104,140,232],"rationally":[2],"identify":[3],"epithelial":[4],"ovarian":[5],"cancer":[6],"(EOC)":[7],"patients":[8,49,77,83,94,190,210,245],"who":[9],"will":[10],"benefit":[11,46],"from":[12,36,73],"bevacizumab":[13,86,193],"or":[14,51],"other":[15],"antiangiogenic":[16],"therapies":[17],"is":[18,30],"a":[19,99,169,234],"critical":[20],"issue":[21],"in":[22,186,206],"EOC":[23,48,76,244],"treatments.":[24],"The":[25,160],"motivation":[26],"of":[27,43,47,181,189,209,221,243],"this":[28,216],"study":[29,217],"quantitatively":[32],"measure":[33],"adiposity":[34,65],"features":[35,227],"CT":[37,71,225],"images":[38,72],"and":[39,90,111,116,132,150,156,179,204,238],"investigate":[40,141],"the":[41,91,142,146,151,176,182,187,207,219,240],"feasibility":[42,220],"predicting":[44],"potential":[45,143],"with":[50],"without":[52,211],"receiving":[53,191,212,246],"bevacizumab-based":[54,248],"chemotherapy":[55,89],"treatment":[56],"using":[57,164,222],"multivariate":[58,124],"statistical":[59,167,229],"models":[60,127,231],"built":[61],"based":[62,228],"on":[63],"quantitative":[64,121,223],"image":[66,226],"features.":[67,122],"A":[68],"dataset":[69],"involving":[70],"59":[74],"advanced":[75],"were":[78,137,197],"included.":[79],"Among":[80],"them,":[81],"32":[82],"received":[84],"maintenance":[85,192,213,247],"after":[87],"primary":[88],"remaining":[92],"27":[93],"did":[95],"not.":[96],"We":[97],"developed":[98],"computer-aided":[100],"detection":[101],"(CAD)":[102],"scheme":[103],"automatically":[105],"segment":[106],"subcutaneous":[107],"fat":[108,113],"areas":[109,114],"(VFA)":[110],"visceral":[112],"(SFA)":[115],"then":[117],"extracted":[118],"7":[119],"adiposity-related":[120,224],"Three":[123],"data":[125],"analysis":[126],"(linear":[128],"regression,":[129],"logistic":[130],"regression":[131],"Cox":[133],"proportional":[134],"hazards":[135],"regression)":[136],"performed":[138],"respectively":[139],"association":[144,172,200],"between":[145,175],"model-generated":[147,177],"prediction":[148,230],"results":[149,161,178],"patients\u2019":[152],"progression-free":[153],"survival":[154,158],"(PFS)":[155],"overall":[157],"(OS).":[159],"show":[162],"that":[163],"all":[165],"3":[166],"models,":[168],"statistically":[170],"significant":[171,199],"was":[173],"detected":[174],"both":[180,202],"two":[183],"clinical":[184,236,241],"outcomes":[185],"group":[188,208],"(p<0.01),":[194],"while":[195],"there":[196],"no":[198],"for":[201],"PFS":[203],"OS":[205],"bevacizumab.":[214],"Therefore,":[215],"demonstrated":[218],"generate":[233],"new":[235],"marker":[237],"predict":[239],"outcome":[242],"chemotherapy.":[249]},"counts_by_year":[],"updated_date":"2026-06-11T09:08:48.828518","created_date":"2025-10-10T00:00:00"}